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Abstract
Background: Growing evidence exists that living with an ICD can lead to fear and avoidance behaviour including
the avoidance of physical activity. It has been suggested that psychological stress can increase the risk of shock
and predict death. Small studies have indicated a beneficial effect arising from exercise training and psychological
intervention, therefore a large-scale rehabilitation programme was set up.
Methods/Design: A mixed methods embedded experimental design was chosen to include both quantitative and
qualitative measures. A randomised clinical trial is its primary component. 196 patients (power-calculated) were
block randomised to either a control group or intervention group at a single centre. The intervention consists of a
1-year psycho-educational component provided by two nurses and a 12-week exercise training component
provided by two physiotherapists. Our hypothesis is that the COPE-ICD programme will reduce avoidance
behaviour, sexual dysfunction and increase quality of life, increase physical capability, reduce the number of
treatment-demanding arrhythmias, reduce mortality and acute re-hospitalisation, reduce sickness leading to
absence from work and be cost-effective. A blinded investigator will perform all physical tests and data collection.
Discussion: Most participants are men (79%) with a mean age of 58 (range 20-85). Most ICD implantations are on
primary prophylactic indication (66%). 44% is NYHA II. Mean walk capacity (6MWT) is 417 m. Mean perception of
General Health (SF-36) is PCS 42.6 and MCS 47.1.
A large-scale ICD rehabilitation trial including psycho-educational intervention and exercise training has been
initiated and will report findings starting in 2011.
Trial Registration: ClinicalTrials.gov: NCT00569478
Background
Treatment with Implanted Cardioverter Defibrillators
(ICD) has reduced mortality remarkably during the
past 20 years. It has resulted in new, more extensive
guidelines for the implantation of ICDs [1]. The aver-
age ICD implantation rate in Europe is 140 per million
inhabitants (in Denmark 180 per million) and in the
USA the rate is considerably higher, 416 per million
[2]. Studies have shown that living with an ICD can
lead to anxiety, fear of shock and avoidance of situa-
tions, places and objects that the patients associate
with shock. It often leads to social isolation, avoidance
of physical activity, including sexual activity and mood
disturbances [3-8]. In addition, it has been suggested
that negative emotions could be the cause rather than
the result of arrhythmia, and that psychological stress
can increase the risk of shock [9-11]. Furthermore, psy-
chosocial status seems to predict mortality [12]. It is
unclear if cardiac rehabilitation can reduce the risk of
shock or death.
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During the past 10 years several, often small, interven-
tional studies have been carried out aiming to improve
every day functioning of patients with ICD.
Exercise training
Patients enrolled in out-patient rehabilitation (OCR)
tend to exercise more often, 4 times a week versus - 3
times a week in the case of non-OCR patients, and with
a higher intensity 5.3 METS (metabolic equivalent) ver-
sus 3.5 METS in non-OCR patients [13]. Exercise train-
ing in a rehabilitation format has been shown to be safe
[14-17], to improve cardiopulmonary fitness e.g. exercise
time [14], METS [18], Peak Vo2 [14-17] and reduce
anxiety [14] and improve quality of life [15].
Psycho-intervention
Psychological [19]/psycho educational [20-22]/cognitive
behavioural [11,23,24] interventions have either a group
format [24] or an individual format [19,20] with face
to face consultations [24] or telephone counselling
[11,19,24]. Psychological intervention seems to have a
beneficial effect on anxiety and perceived physical health
in patients younger than 65 years but may lead to symp-
tom increase in older patients [19]. Psycho-educational
intervention seems to reduce anxiety [20,21,25] and
enhance knowledge [20]. However in the computer based
format there were no beneficial effects [22]. Cognitive
behavioural rehabilitation has shown to improve physical
health, reduce anxiety [11,23] and depression, and lower
unplanned admissions [23]. However in a group format
no difference in quality of life was found [24].
Combined interventions
A few randomized trials have combined exercise train-
ing and cognitive behavioural intervention. In a study by
Frizelle et al. from 2004, 22 patients were included, half
in an intervention group and half in a waiting group,
beginning rehabilitation after 3 months. The interven-
tion consisted of a weekly two-hour group meeting over
a 6 week period and a follow up telephone call at 9
weeks. Significant improvements in anxiety, depression,
quality of life and physical capacity were observed [26].
Similarly Fitchet et al. compared 16 patients randomised
either to a 12 week (twice weekly) rehabilitation pro-
gramme or a waiting group, beginning rehabilitation
after 3 months. The intervention consisted of exercise
training and psycho-educational intervention in a group
format. This resulted in improved exercise time, and
reduced anxiety and depression [27].There have been
calls for a well-powered study combining psycho-educa-
tional intervention and exercise training [21]. We have
now developed and completed enrolment for just such a
study. The purpose of the COPE-ICD trial, to our
knowledge, the largest randomised clinical intervention
trial studying ICD rehabilitation, is to describe the effect
and meaning of an outpatient programme including
psycho-educational consultations and exercise training
for patients with ICD. This paper summarises the
study design and the baseline characteristics of the
participants.
Hypothesis
Our hypothesis is that the COPE-ICD programme will:
• reduce avoidance behaviour and increase quality of
life
• reduce fear of exercise and increase physical
capability.
• reduce sexual dysfunction
• reduce the number of treatment-demanding
arrhythmias and ICD shocks.
• reduce mortality
• reduce acute re-hospitalization
• reduce sickness absence and improve employment
status in the long term
• be cost effective
Methods/Design
Trial design
The COPE-ICD trial combines quantitative and qualita-
tive research methods. The methods are integrated by
applying a mixed methods embedded experimental
design (Figure 1) [28]. The quantitative method utilises
the traditional randomised controlled trial (RCT). The
qualitative methods utilises extensive interviews of a
small selected subset of intervention patients. The quali-
tative data will help explain the quantitative findings.
The rationale for this approach is that the quantitative
data and their subsequent analysis provide a general
understanding of the research problem. The qualitative
data and their analysis refine and explain the statistical
results by exploring participants’ views in more depth.
Participants
The setting is a large university hospital with a volume
of approximately 300 first time ICD implantations every
year.
Eligibility
Inclusion - Patients who received an ICD for the first
time, and who prior to hospital discharge agreed to
participate in the entire programme.
- Patients with physician permission prior to rando-
mization to participate in the physical training
programme.
Exclusion - Patients who do not understand the study
instructions.
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- Patients who are under 18 years of age.
- Patients who are diagnosed with a psychiatric
disease.
- Patients with other somatic diseases, where recov-
ery might influence the study.
Randomisation
Before randomisation baseline data were collected.
Patients were randomised while in hospital.
The enrolling research assistant or primary investiga-
tor called for randomization allocation. Randomisation
(block of 4) was done by voice-respondent in a 1:1 ratio
to intervention group or control group (standard care)
and there was stratification according to gender and left
ventricular ejection fraction (below or above 35%).
Intervention COPE-ICD
Psycho-educational intervention
The programme is based on a humanistic approach,
focusing on psychosocial support and education. The
programme is directed towards the parameters that
ICDs reportedly affect. The content is made up of infor-
mation and education focused on managing life with an
ICD, including emotional reactions (Table 1) using a
holistic view on the person and establishment of a joint
approach to disease management and coping. Nursing
care is inspired by R.R Parse’s Human Becoming Prac-
tice Methodologies 3 dimensions [29] that are inter-
preted as: 1, discuss and give meaning to the past,
present and future 2, explore and discuss events and
possibilities and 3, move along with envisioned possibili-
ties. According to this theory there are 3 ways of chan-
ging health: creative imaging that is see, hear and feel
what a situation might be like if lived in a different way,
affirming personal patterns and value priorities, and
shedding light on paradoxes, that is looking at the
incongruence in a situation and changing the view held
of something. The nurse is true present in the process
through discussions, silent immersion and reflection.
The consultations take place in a quiet setting at the
out-patient clinic. The nurse is able to facilitate contact
to or seek advice with a physician or a technician.
The patients consult the nurse in person or by phone
once a month for 6 months, and every 2 months there-
after, for the following 6 months. The frequency is
based on clinical experience where transportation to the
hospital and the need for psycho-educational support
are considered. Relatives are invited to participate once
or twice if needed. The psycho-educational part of the
intervention is performed by two nurses with 10 years
of clinical experience each in the care for patients with
ICDs. The nurses do not care for ICD patients at the
in-hospital unit during the project period to prevent
“contamination” of the control group.
Exercise training program
Three months after the ICD implantation, training is
done twice a week for twelve weeks. The three month
delay was chosen to secure stability [20]. The physical
training program consists of an individual consultation
with the physiotherapist and an individually tailored
training programme. A test of aerobic functioning,
patients’ experiences and usual activities are elements in
planning an individual programme. Patients do both
resistance and aerobic training, to gain muscle strength
and endurance and to gain reduction in after load with
a decrease in systemic resistance [30]. The training has
either a supervised group format in-hospital or is done
at home or in a local hospital rehabilitation setting. The
patients use pulse watches while exercising, to ensure
that the recommended intensity of the training pro-
gramme is obtained, and to ensure that the ICD activa-
tion threshold is not reached. During the physical
training the pulse is noted, at 4 specific times. The
            
QUAN= Qantitative measures (primary outcome mesures) 
qual= Qualitative measures (secundary supportive measures) 
Randomized Controlled Trial
Intervention qual after
intervention
QUAN 
premeasure
QUAN
postmeasure
Figure 1 Trial Design.
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patients exercise aerobically, at 50-80% of their esti-
mated maximum pulse, calculated by the Karvonen for-
mula [31]. The target exercise heart rate is close to 80%
of their maximum capacity. Patients are encouraged to
exercise intensively, to obtain the maximum effect of
the training, but not to fatigue themselves. Resistance
training is done by 60-80% of one-repetition maximum
(1-RM). The training pulse is allowed to rise to a maxi-
mum 10 - 15 beats below the ICD activation threshold
[30]. To obtain cardiovascular adjustment, it is impor-
tant to warm up and cool down, to minimize the risk of
ischemia and arrhythmia [27,32]. The patients primarily
exercise in an upright position, to reduce left ventricular
filling pressure and minimize the risk of ischemia or
heart failure ventricular arrhythmia [32].
Group training at the hospital The exercise training
takes place in a supervised group with planned elements
that are individually adjusted with respect to capacity,
and risk of injuries.
One session consists of the following; 10 min. warm
up, 8 min. biking, 8 min. walking/jogging/running, 8
min. individual aerobic endurance training e.g. step,
stairway or running and resistance training of the major
muscle groups. The session ends with 10 min. cool
down and relaxation. Two physiotherapists with 2-3
years of experience each ran the exercise training
programme.
Home training Patients that cannot not attend exercise
training at the hospital, are given an individual pro-
gramme based on the above principles and instructed
how to use a pulse watch with extended memory to
monitor all training sessions. This is done in order to
guide patients and to ensure adherence to instructions.
An overview of the intervention timeline and data col-
lection is presented in Figure 2.
Standard care
Patients in the control group follow the standard care
procedure, which is medical follow-up and an invitation
to participate in a 2 hour group meeting, which includes
information about the ICD and exchange of experiences
among patients. In the standard care group no psycho-
educational follow-up or exercise training are provided. A
bias may occur if patients are offered cardiac rehabilita-
tion at their local hospital. As a national law encourages
rehabilitation for all cardiac patients, it is not possible to
completely avoid participation in local initiatives. Patients
are asked whether they had participated in such activities
at the12 months follow-up.
Outcomes
Using questionnaires, interviews, exercise-tests, a 6-min-
ute walk test (6-MWT), interrogation of the ICD and
register-based follow-up, the effect and meaning of the
programme are evaluated (Table 2). The pre-training
exercise test is performed at 3 months and therefore not
reported here.
Primary outcome measures: Due to the nature of
rehabilitation, including both physical and psychological
components, the two primary outcome measures are
perceived health measured by the Short Form-36 [33,34]
questionnaire and Peak VO2, measured by a standar-
dized protocol according to guidelines [35]. The test is
performed on bicycle ergometer with an initial workload
of 12.5 W and increased 12.5 w every minute until
exhaustion or at 5 beats/min heart rate below ICD
activation threshold. No gas analyses are conducted.
Secondary outcome measures: Physical capability is
measured by an exercise test combined with the six min-
utes walk tests which have been proved to be effective
measures of functional capacity in patients performing
Table 1 Inspiration Guide for Nursing Consultations
1 2 3 4 5 6 7 8 9
What happened since you were here last time? How have you been? x x x x x x x x x
Discuss the events leading up to the ICD implant. Experiences before and during admission. x
Address present thoughts and questions x x x x x x x x x
Were there any episodes from the ICD? x x x x x x x x x
How did you having an ICD affect your life? Are there any activities you avoid? Are there any places you avoid? Are
there objects you avoid?
x
Did you make an appointment with the physiotherapist/how is training going? x x x x x x x
Discuss family, how do they tackle, changing patters in the family? x x x
Information, technical/recommendations. x x
Shock (ad hoc)/phantom shock x
Changing view on the body? x
Driving x
Sexuality, is this affected? x x
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cardiac rehabilitation [30,36,37]. Further, exercise training
data consist of the number of sessions, duration and
heart rate.
Ventricular arrhythmia: 1. ICD-shock 2. Anti-tachycar-
dia pacing is registered by interrogation of the ICD.
Questionnaires: Quality of life is measured by Quality
of Life Index-Cardiac version (QLI-C) [38], knowledge
of the ICD by Sudden Cardiac Death (SCD) knowledge
assessment [20], ICD-adaptation using Implanted
Devices Adjustment Scale (IDAS) [39], sexual problems
or dysfunction by the Sex After ICD Survey [40] and
avoidance behaviour is measured by ICD and Avoidance
Survey [40].
Ancillary questions developed for this study: amount of
participation in rehabilitation outside the project, and
work status/sick leave before and after ICD implantation.
Registry data: Registry data is collected regarding death,
hospitalisation, emergency room visits, outpatient visits,
medication and employment status. The national registries
function very well with a small percentage of lost data and
thus are well suited to measure effects, even in small
patient populations. Data is extracted from the Danish
National Patient Register, the Danish National Health Ser-
vice Register, the Danish National Prescription Registry
and the Danish National Causes of Death Register.
Demographic variables and diagnoses are collected
from medical records.
The qualitative study:
The qualitative study seeks to answer the following
questions in order to fulfil the purpose of the trial:
Thematic research questions:
- What are the experiences of participating in the
COPE-ICD program?
- What is the meaning of participating in the
program?
- Which components of the outpatient program are
meaningful, and how are they meaningful?
Intervention         Data collection
1 time ICD implantation        Baseline data collection 
Phase 1 
Nurse consultations once a 
month 
        3-month data collection 
Phase 2 
Nurse consultations once a 
month 
Exercise training 2 times a 
week for 12 weeks 
        6-month data collection 
Phase 3 
Nurse consultation every  
2´nd month 
        12-month data collection
         
        36-month data collection
Figure 2 Timeline.
Table 2 Outcome Measures
Measurement Time
SF-36 Baseline, 3-6-12 month
QLI-C Baseline, 3-6-12 month
IDAS Baseline, 3-6-12 month
Sex after ICD survey 6 month
ICD and Avoidance Survey 6-12 month
SCA knowledge assessment Baseline, 12 month
Exercise test, 6MWT 3-6 month
ICD interrogation 3-6-12 month
Work 12 month
Rehabilitation elsewhere 12 month
Qualitative interview 12 month
Registry data 2 years
SF-36 and exercise test are primary outcome measures.
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Ten patients (10%) from the intervention group are
interviewed at the end of intervention. Qualified inter-
viewees are chosen (knowledgeable, articulate), represen-
tative in terms of stratification, gender and left
ventricular ejection fraction (LVEF) and according to
the reason for ICD implantation (primary/secondary
prevention) to achieve maximum variation [41]. The
analysis is inspired by Ricoeur’s theory of interpretation
and consists of three levels: naive reading, structured
analysis and critical interpretation and discussion [42].
Sample size
Physical capacity
Based on current knowledge (1), we estimate a differ-
ence in V02max of 15% between the rehabilitation
group and standard care group (SD = 0.3). A total num-
ber of 128 patients are estimated for the trial (alfa = 5%,
beta = 20%). Health status outcome measure: Based on
health status measures among a Danish population com-
pared to patient with heart disease a baseline mean-
score of the SF-36 general health (GH) is estimated to
be 60 (SD = 22). The effect of rehabilitation is expected
to be 10 absolute points. A total number of 154 patients
are needed in the trial (alfa = 5%, beta = 20%). The
study includes 196 patients, taking a drop-out rate of
20% into account. In the previous trials a drop-out rate
around 20% was found, with no significant differences
in baseline information on any study variable between
groups and no difference in the number of dropouts in
each group [11,17,19,21,23].
Blinding
Because of the nature of rehabilitation, the interventions
are open to the staff and the patients. A blinded investi-
gator performs all physical tests, data collection and
administration. Blinded outcome analyses are conducted.
Statistical methods
The statistical analyses of the effects of rehabilitation are
conducted based on a predefined statistical protocol
using SPSS 17.0 for Windows. The analysis will adopt
an analytical approach on all available data, meaning
that all data obtained are included in analyses, regardless
of adherence to the study protocol. Only data from
patients following through the program will be included
in the analysis of the endpoints. Accordingly, there is no
imputation of missing data. Questionnaire responses will
be converted to numerical scores using standard meth-
odologies. Continuous data are checked for normality of
distribution, and log-transformed if required. The base-
line characteristics will be presented by group to present
similarities across treatment, but according to recom-
mendations no significant testing will be performed
[43]. The socio-demographic and clinical characteristics
of individuals who drop out from the study will be com-
pared with those who completed the study and drop-out
characteristics between groups will be compared. The
effectiveness of the intervention will be examined using
blinded analysis of variance. The primary comparisons
will be Two independent samples T-test for the mean
difference between two independent samples. Paired T-
tests of equality of means will be used for within group
analysis of difference over time. Further, univariable and
multivariable regression analysis will also be used to
investigate the effect of the intervention on the end-
points. The type of regression analysis will depend on
the endpoint in question. Demographic, clinical and
questionnaire data will be included in multivariable ana-
lysis in order to control for their potential confounding
effects. The level of significance is set at p < 0.05. Data
will, for continues data, be shown as means ± standard
deviation or percentage. Categorical data will be shown
as percent. Twelve month follow-up data and results
obtained from Danish registries regarding hospitalisa-
tions are used for follow-up comparison. Due to the
skewed distribution of length of hospital stay and
repeated measurements of hospital admissions on
patients these register-based tertiary outcomes will be
analyzed using multivariate random-effect modelling
with patients as random effects. Further analysis will be
conducted using the Cox regression model including
time to first event as outcome variable. At baseline 46%
(n = 91) of the population was employed. This is a
rather small number of patients and sickness absence
will be included as a measure when evaluating employ-
ment status. The direct costs of healthcare are calcu-
lated by a retrospective top-down method [44]. All
other costs are extracted from relevant registers.
Ethical considerations
The study is approved by the regional Ethics Committee
(j.nr. H-B-2007-014), National Agency for Data Security
(j.nr. 2007-41-0932) and registered at ClinicalTrials.gov
(ID: NCT00569478). Patients were asked to participate
in the study after receiving oral and written information,
and were given time to reflect on their participation in
the study before giving written informed consent. All
data are treated in confidence and patients are assured
anonymity. The study follows the recommendations of
the Declaration of Helsinki II [45].
Safety
No risks are anticipated during the psycho-educational
consultations.
Studies have shown that it was safe for patients with
ICDs to participate in physical training [13,16,27]. This
intervention is not aimed at maximum performance, but
is a recreational programme. A “cool down” period was
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incorporated in exercise and testing, which has pre-
viously resulted in 45,000 exercise tests without compli-
cations over a 10 year period [46].
Participants recruitment and flow
During the inclusion period October 2007-November
2009, 610 patients had ICD implantation at the hospital
(Figure 3). Due to local policies patients were not asked
to participate if they were eligible for or included in
pharmaceutical trials. Not meeting the inclusion criteria
was due to other somatic diseases (n = 49), psychiatric
disease or cognitive dysfunction (n = 20) and language
(n = 11). A total of 196 patients were included.
Baseline measures
Most participants are men (79%) and the mean age
was 58 (SD 13.2), range 20-85. The mean LVEF is 32
(SD17.5) and most (46%) are NYHA class 2 and 64%
received the ICD for primary prevention (Table 3). The
medication status at baseline is presented in Table 4.
The mean walk capacity measured by 6MWT is 417 m.,
Table 5. The perception of health measured by SF-36
is 42.6 for physical component scale (PCS) and 47.1
for mental component scale (MCS), a higher score indi-
cating better perception of health, scale range 0-100
(Table 6). Quality of life score is 26.4 (Table 6), scale
range from 0-36, a higher score indicating better
quality of life. Baseline knowledge of the ICD score is
20 (Table 6), scale range 0-25.
Discussion
Demographic data and clinical variables are similar
between the groups. The baseline characteristics are
similar to other ICD rehabilitation populations regarding
NYHA, LVEF, gender, type of device and indication
[20,21]. The baseline measures of knowledge and skills
needed to live with an ICD, SCA Knowledge score 20,
are similar to the ICD rehabilitation population that
Assessed for eligibility
(n=610)
Excluded (n=414)
- Did not meet inclusion criteria  
(n=80)
- Included in other research
projects (n=94)
- Missed (n=34)
- Refused consent (n=206)
Reasons: 
Did not want to participate  
(n=96)
Distance to hospital (n=82)
No reason listed (n=28)
Randomized
(n=196)
Intervention (n=99) Control (n=97)
Figure 3 Flowchart of Patients Included in COPE-ICD.
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originally tested the questionnaire, score 21 [20]. The
population is also similar to other ICD populations
regarding quality of life, with very similar scores in all
subscales [47,48]. Perceived health measured by SF-36 is
also similar to other findings as to the mental and emo-
tional health, but with somewhat higher scores in physi-
cal function and pain [48].
Testing 6-MWT showed that this population might
have a higher physical capacity (417 m) than other ICD
populations (328 m, 383 m) [49,50], which can possibly
be explained by a slightly higher LVEF and younger age.
This intervention is expensive from a rehabilitation
perspective with 9 nurse consultations, 2 individual con-
sultations with a physiotherapist and 2 weekly exercise
training group sessions offered at the hospital. The
planned economic analysis will reveal the cost-benefit
ratio of this comprehensive rehabilitations programme.
The set-up of this programme can be done in any car-
diac rehabilitation setting after proper education of
nurses and physiotherapists.
Study limitations include the fact that that selection
bias may exist due to patients not being included if they
were already included in a pharmaceutical trial. The
control group might be contaminated by the informa-
tion given during the project inclusion, suggesting that
psycho-educational assistance and exercise training
might be beneficial after ICD implantation. This infor-
mation could lead to control patients seeking rehabilita-
tion elsewhere if they believe it is effective. There is an
Table 4 Baseline Medication
Control gr. n (%) Intervention gr. n (%)
Betablockers 83 (86) 76 (76)
Calcium antagonist 6 (6) 18 (18)
Amiodarone 8 (8) 11 (11)
ACE inhibitors 67 (69) 69 (69)
Digoxin 8 (8) 12 (12)
Prolonged nitrates 7 (7) 4 (4)
Insulin 4 (4) 5 (5)
Table 3 Demographic and Physical Profile
Control
gr. n (%)
Intervention
gr. n (%)
Male gender 76 (78) 79 (80)
Age (mean) 58 58
Employed 50 (52) 41 (42)
Primary prophylactic indication 67 (69) 63 (64)
VF prior to ICD implantation 20 (20) 21 (21)
LVEF (mean/SD) 73% of tot pop ≤ 35 32.7 (18) 32.2 (17)
NYHA I 18 (19) 30 (31)
NYHA II 44 (46) 42 (43)
NYHA III 32 (33) 24 (25)
NYHA IV 1(1) 2 (2)
BMI ≥ 30 19 (20) 24 (24)
Atial fibrillation 21 (22) 27 (27)
CRT device 9 (9) 14 (14)
History of IHD 57 (59) 45 (46)
Previous MI 33 (34) 20 (21)
Previous PCI 29 (30) 28 (29)
Previous CABG 21 (22) 14 (15)
History of HF 73 (75) 76 (78)
Diabetes 10 (10) 12 (12)
Hypertension 23 (24) 18 (18)
COLD 1 (1) 2 (2)
Other chronic disease 24 (25) 27 (28)
CRT: Coronary resync. therapy. IHD: Ischemic heart disease. MI: Myocardial
infarction. PCI: Percutaniuos catheter intervention. CABG: Coronary artery
bypass graft. HF: Heart failure. COLD: Chronic Obstructive Lung Disease.
Table 5 6 MWT Baseline
Control gr.
score.
Intervention gr.
score.
Distance meter (SD) 415 (118) 420 (112)
*Shortness of breath Pre-test
(CI)
1.1 (0.7-1.3) 0.9 (0.5-1.3)
*Shortness of breath Post-test
(CI)
3.2 (2.6-3.8) 2.8 (2.2-3.4)
*Exertion pre-test (CI) 2.1 (1.5-2.7) 1.7 (1.3-2.3)
*Exertion post-test (CI) 2.5 (1.8-3.1) 2.2 (1.5-2.8)
*BORG CR 10 Scale.
Mean values and 95% confidence interval
Table 6 SF-36, QoL -cardiac version, SCA knowledge.
Control gr. score,
mean (SD)
Intervention gr. score,
mean (SD)
PCS 43.4 (8.5) 41.9 (10.2)
MCS 46.7 (11.5) 47.4 (10.4)
Physical Function 69.8 (22.6) 69.7 (21.4)
Role Physical 39.1 (42.3) 36.6 (42.7)
Bodily Pain 71.2 (27.7) 71.2 (27.1)
General Health
Perceptions
59.5 (19.2) 58.7 (21.9)
Vitality 53.5 (22.8) 55.6 (22.9)
Social Functioning 77.7 (24.9) 76.8 (25.9)
Role Emotional 56.3 (39.1) 51.0 (43.7)
Mental Health 69.3 (21.3) 72.5 (20.6)
QLI 26.5 (5.3) 26.3 (6.3)
HFSUBa 23.4 (5.7) 23.5 (6.9)
SOCSUBb 29.9 (6.4) 29.6 (7.1)
PSPSUBc 26.8 (9.4) 26.0 (8.2)
FAMSUBd 30.0 (5.1) 29.6 (8.7)
SCA knowledge 20.1 (3.1) 20 (3.7)
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expected drop-out rate at 20% which could influence the
validity. Any difference between patients completing the
intervention and those not completing (drop-outs) will
be carefully discussed in evaluating the intervention,
results and the suitability for implementation. The trial
is designed with multiple statistical comparisons so
results will be interpreted with caution.
In conclusion, whether a comprehensive rehabilitation
programme improves quality of life and physical func-
tion have so far not been tested in larger prospective
randomized controlled trials. The COPE-ICD trial is
designed to test this hypothesis. The baseline data indi-
cate a study population with heart failure, representative
for ICD patients in general, similar to previous studies.
This is the largest randomized trial in ICD patients to
date, and will help determine the value of a comprehen-
sive rehabilitation programme. Furthermore, the study’s
results will undoubtedly impact on rehabilitation prac-
tice and the control group in this study will provide
valuable information on the current natural history of
contemporary ICD patients. The first results will be
published in 2011.
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